Skip to main content

Table 2 Recovery and matrix effect of zanubrutinib in rat plasma (n = 6)

From: A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal

Analyte

Concentration (ng/mL)

Recovery (%)

Matrix effect (%)

Mean ± SD

RSD(%)

Mean ± SD

RSD(%)

Zanubrutinib

2

92.0 ± 10.2

11.1

104.4 ± 9.9

9.5

40

98.2 ± 11.4

11.6

97.5 ± 6.0

6.1

800

97.0 ± 5.8

6.0

106.3 ± 6.6

6.2